Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
-15.61%
End price
04.05.25
€246.85
Summary
This prediction ended on 04.05.25 with a price of €246.85. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.61%. BMO_Capital_Markets has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.50 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -2.373% | -2.373% | 7.952% |
| iShares Core DAX® | 2.032% | 3.499% | 24.306% |
| iShares Nasdaq 100 | -0.145% | -1.849% | 5.004% |
| iShares Nikkei 225® | 4.507% | 1.976% | 16.735% |
| iShares S&P 500 | 0.331% | -0.103% | 3.168% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten